Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cemtrex (CETXP) EBITDA (2016 - 2025)

Cemtrex filings provide 16 years of EBITDA readings, the most recent being -$2.8 million for Q4 2025.

  • On a quarterly basis, EBITDA fell 23.0% to -$2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14898.0, a 99.78% increase, with the full-year FY2025 number at $509826.0, up 109.67% from a year prior.
  • EBITDA hit -$2.8 million in Q4 2025 for Cemtrex, down from -$1.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $4.6 million in Q1 2025 to a low of -$8.5 million in Q3 2021.
  • Median EBITDA over the past 5 years was -$982361.5 (2022), compared with a mean of -$1.4 million.
  • Biggest five-year swings in EBITDA: plummeted 6012.74% in 2024 and later surged 547.31% in 2025.
  • Cemtrex's EBITDA stood at -$4.5 million in 2021, then soared by 56.35% to -$2.0 million in 2022, then soared by 62.16% to -$738372.0 in 2023, then crashed by 208.98% to -$2.3 million in 2024, then dropped by 23.0% to -$2.8 million in 2025.
  • The last three reported values for EBITDA were -$2.8 million (Q4 2025), -$1.2 million (Q3 2025), and -$642401.0 (Q2 2025) per Business Quant data.